NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$5.42 and traded as high as C$5.63. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.60, with a volume of 397,233 shares.
Analyst Ratings Changes
NWH.UN has been the topic of a number of analyst reports. ATB Cormark Capital Markets lowered shares of NorthWest Health Prop Real Est Inv Trust from an "outperform" rating to a "sector perform" rating and set a C$6.25 target price on the stock. in a report on Friday, February 27th. Royal Bank Of Canada upped their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$6.00 and gave the stock a "sector perform" rating in a report on Wednesday, March 4th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of C$6.20.
Read Our Latest Report on NorthWest Health Prop Real Est Inv Trust
NorthWest Health Prop Real Est Inv Trust Stock Performance
The firm has a market capitalization of C$1.39 billion, a P/E ratio of -26.49, a price-to-earnings-growth ratio of 0.74 and a beta of 1.63. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The business's 50 day simple moving average is C$5.61 and its two-hundred day simple moving average is C$5.42.
NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) last released its quarterly earnings data on Tuesday, February 24th. The company reported C($0.16) earnings per share for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. The firm had revenue of C$102.27 million for the quarter. Sell-side analysts anticipate that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current fiscal year.
NorthWest Health Prop Real Est Inv Trust Company Profile
(
Get Free Report)
Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.
While NorthWest Health Prop Real Est Inv Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.